Insider Sale by Coloma Jason V (Chief Executive Officer)
Trade Summary
1 week ago, Coloma Jason V, serving as Chief Executive Officer at Maze Therapeutics, Inc. (MAZE), sold 22,638 shares at $26.24 per share, for a total transaction value of $593,954.88. Following this transaction, Coloma Jason V now holds 27,362 shares of MAZE.
This sale represents a 45.28% decrease in Coloma Jason V's stake in the company. This is considered a high-conviction trade given the significant change in ownership.
The trade was executed on Wednesday, September 2, 2026 and publicly disclosed via SEC Form 4 filing on Friday, September 4, 2026 at 4:24 PM ET, 2 days after the trade was made.
Maze Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.
Trade Price
$26.24
Quantity
22,638
Total Value
$593,954.88
Shares Owned
27,362
Trade Date
8 days ago
SEC Filing Date
at 4:24 PM ET
Filed 2 days after trade
Discussion